1 study found for:    "Limb-girdle muscular dystrophy type 2C"
Show Display Options
Rank Status Study
1 Completed Clinical Study of AAV1-gamma-sarcoglycan Gene Therapy for Limb Girdle Muscular Dystrophy Type 2C
Conditions: Limb Girdle Muscular Dystrophy Type 2C;   Gamma-sarcoglycanopathy
Intervention: Biological: AAV1-gamma-sarcoglycan vector injection

Indicates status has not been verified in more than two years